ADARx Pharmaceuticals, Inc.
Funding history
About ADARx Pharmaceuticals, Inc.
How much funding has ADARx Pharmaceuticals, Inc. raised?
ADARx Pharmaceuticals, Inc. has raised $200.0M in total funding. The most recent round was Series C.
Where is ADARx Pharmaceuticals, Inc. headquartered?
ADARx Pharmaceuticals, Inc. is headquartered in San Diego, CA.
What problem does ADARx Pharmaceuticals, Inc. solve?
Unmet treatment needs across genetic, complement-mediated, cardiovascular, cardiometabolic, CNS, and metabolic chronic diseases where other treatment modalities fall short.
What's ADARx Pharmaceuticals, Inc.'s solution?
ADARx develops a pipeline of RNA medicines using its RNA science expertise and proprietary targeted delivery platforms to precisely silence the underlying cause of disease.
What makes ADARx Pharmaceuticals, Inc. different?
The company points to proprietary targeted delivery platforms and RNA medicines designed for improved potency, precision, and durability compared to other treatment modalities.
What makes ADARx Pharmaceuticals, Inc. notable?
Has raised over $350 million from major healthcare investors including OrbiMed, BlackRock, and Bain Capital Life Sciences.
Leadership
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.